MONOSHOT HA + PRP
Products
Information
Monoshot(TM) HA+PRP is a combination of hyaluronic acid (HA) with platelet-rich plasma (PRP), intended for intra-articular injection. Product provides simultaneous mechanical and anti-catabolic action of HA with optimally selected physicochemical parameters and the anabolic action of growth factors secreted by platelets from PRP. Thus, clinical effectiveness of the therapy based on Monoshot(TM) HA+PRP is strictly linked to the combined action provided by each of its component- HA and growth factors released by PLTs. Monoshot(TM) HA, with selected optimal viscoelastic properties provides not only the mechanical effect, like improved lubrication and adsorption of forces acting in the joint. On the other hand, PRP obtained with the Monoshot(TM) PRP separation device is a highly concentrated PLT solution, characterized by platelets concentration way above 1 000 000 PLT/Mul- a threshold of a therapeutical effectiveness for PRP2.
Distribution Areas
OceaniaNorth America (USA, Canada)AfricaMiddle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied From
Poland
All categories
Biopharmaceutical ProductsFinished Dosage FormsInjectablesRegenerative MedicinePharmaceutical Machinery & TechnologyMedical DevicesProducts
Main Categories
Biopharmaceutical ProductsFinished Dosage FormsPharmaceutical Machinery & Technology
